University of Cape Town HIV and TB Clinical Trials Unit
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
This program runs clinical trials of new and improved HIV and tuberculosis treatments and prevention methods for people living in and around Cape Town, South Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cape Town NIH-funded |
| Lab location | 1 site (Rondebosch, South Africa) |
| Project ID | NIH-11234234 on NIH RePORTER |
What this research studies
You would be connecting with a clinical trials unit based at the Desmond Tutu HIV Centre that runs studies in communities around Cape Town where HIV and TB are common. The unit supports six local research sites and offers treatment and prevention trials for HIV, tuberculosis, and related sexually transmitted infections. Trials involve regular clinic visits, medical exams, and may include blood or other sample collection to track health and study how treatments work. Joining a trial could mean closer medical monitoring and access to new therapies under careful supervision.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV or tuberculosis, or those at elevated risk of these infections in the Cape Town area who meet specific trial eligibility criteria.
Not a fit: People who live far from Cape Town, who do not meet trial eligibility rules, or whose condition is unrelated to HIV/TB are unlikely to directly benefit from these specific trials.
Why it matters
Potential benefit: If successful, this work could bring better treatments and prevention options for people with HIV and tuberculosis in southern Africa and beyond.
How similar studies have performed: Many prior clinical trials in HIV and TB have led to effective medicines and prevention tools, and this program builds on that well-established track record.
Where this research is happening
Rondebosch, South Africa
- University of Cape Town — Rondebosch, South Africa (Active)
Researchers
- Principal investigator: Bekker, Linda-Gail Gail — University of Cape Town
- Study coordinator: Bekker, Linda-Gail Gail
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.